Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

NCT05798546 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: Neo-T
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2

Sponsor

BGI, China

Collaborators

[object Object]